Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ping-Ping Li

Showing results (121-130 of 134) with videos related to

Pageof 14
Sort By:
Evidence-Based Complementary and Alternative Medicine : Ecam|March 28, 2013
QiShenYiQi Pills, a Compound Chinese Medicine, Ameliorates Doxorubicin-Induced Myocardial Structure Damage and Cardiac Dysfunction in RatsDong-Xin Tang, Hai-Ping Zhao, Chun-Shui Pan, et al.
Applied Microbiology and Biotechnology|October 12, 2020
A novel Rap-Phr system in Bacillus velezensis NAU-B3 regulates surfactin production and sporulation via interaction with ComAZhao Liang, Jun-Qing Qiao, Ping-Ping Li, et al.
Oncotarget|June 11, 2016
MicroRNA-33a-3p suppresses cell migration and invasion by directly targeting PBX3 in human hepatocellular carcinomaShu-Yan Han, Hai-Bo Han, Xiu-Yun Tian, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 26, 2026
Adiposity shapes the immune architecture independent of antibody responses in mild SARS-CoV-2 InfectionAmy May Lin Quek, Delicia Shu Qin Ooi, Ooiean Teng, et al.
Science Translational Medicine|January 5, 2022
TRIB3 reduces CD8<sup>+</sup> T cell infiltration and induces immune evasion by repressing the STAT1-CXCL10 axis in colorectal cancerShuang Shang, Yu-Wei Yang, Fei Chen, et al.
Immunity|October 13, 2021
The chemokine CCL1 triggers an AMFR-SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosisShan-Shan Liu, Chang Liu, Xiao-Xi Lv, et al.
Immunity|August 18, 2021
The chemokine CCL1 triggers an AMFR-SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosisShan-Shan Liu, Chang Liu, Xiao-Xi Lv, et al.
Nature Communications|January 3, 2024
Targeting IL-17A enhances imatinib efficacy in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemiaFeng Wang, Yunxuan Li, Zhaona Yang, et al.
Nature Communications|December 18, 2019
TRIB3 supports breast cancer stemness by suppressing FOXO1 degradation and enhancing SOX2 transcriptionJin-Mei Yu, Wei Sun, Zhen-He Wang, et al.
Immunity|June 25, 2025
Targeting Degradation of the Transcription Factor C/EBPβ Reduces Lung Fibrosis by Restoring Activity of the Ubiquitin-Editing Enzyme A20 in MacrophagesShan-Shan Liu, Xiao-Xi Lv, Chang Liu, et al.
Pageof 14

Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
Evidence-Based Complementary and Alternative Medicine : Ecam|March 28, 2013
QiShenYiQi Pills, a Compound Chinese Medicine, Ameliorates Doxorubicin-Induced Myocardial Structure Damage and Cardiac Dysfunction in RatsDong-Xin Tang, Hai-Ping Zhao, Chun-Shui Pan, et al.
Applied Microbiology and Biotechnology|October 12, 2020
A novel Rap-Phr system in Bacillus velezensis NAU-B3 regulates surfactin production and sporulation via interaction with ComAZhao Liang, Jun-Qing Qiao, Ping-Ping Li, et al.
Oncotarget|June 11, 2016
MicroRNA-33a-3p suppresses cell migration and invasion by directly targeting PBX3 in human hepatocellular carcinomaShu-Yan Han, Hai-Bo Han, Xiu-Yun Tian, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 26, 2026
Adiposity shapes the immune architecture independent of antibody responses in mild SARS-CoV-2 InfectionAmy May Lin Quek, Delicia Shu Qin Ooi, Ooiean Teng, et al.
Science Translational Medicine|January 5, 2022
TRIB3 reduces CD8<sup>+</sup> T cell infiltration and induces immune evasion by repressing the STAT1-CXCL10 axis in colorectal cancerShuang Shang, Yu-Wei Yang, Fei Chen, et al.
Immunity|October 13, 2021
The chemokine CCL1 triggers an AMFR-SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosisShan-Shan Liu, Chang Liu, Xiao-Xi Lv, et al.
Immunity|August 18, 2021
The chemokine CCL1 triggers an AMFR-SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosisShan-Shan Liu, Chang Liu, Xiao-Xi Lv, et al.
Nature Communications|January 3, 2024
Targeting IL-17A enhances imatinib efficacy in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemiaFeng Wang, Yunxuan Li, Zhaona Yang, et al.
Nature Communications|December 18, 2019
TRIB3 supports breast cancer stemness by suppressing FOXO1 degradation and enhancing SOX2 transcriptionJin-Mei Yu, Wei Sun, Zhen-He Wang, et al.
Immunity|June 25, 2025
Targeting Degradation of the Transcription Factor C/EBPβ Reduces Lung Fibrosis by Restoring Activity of the Ubiquitin-Editing Enzyme A20 in MacrophagesShan-Shan Liu, Xiao-Xi Lv, Chang Liu, et al.
Pageof 14